These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38608634)

  • 1. SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues.
    Carter TR; Milosevich N; Dada L; Shaum JB; Barry Sharpless K; Kitamura S; Erb MA
    Bioorg Med Chem; 2024 Apr; 104():117699. PubMed ID: 38608634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cereblon target validation using a covalent inhibitor of neosubstrate recruitment.
    Dann GP; Liu H; Nowak RP; Jones LH
    Methods Enzymol; 2023; 681():155-167. PubMed ID: 36764755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A platform for the rapid synthesis of molecular glues (Rapid-Glue) under miniaturized conditions for direct biological screening.
    Li J; Li C; Zhang Z; Zhang Z; Wu Z; Liao J; Wang Z; McReynolds M; Xie H; Guo L; Fan Q; Peng J; Tang W
    Eur J Med Chem; 2023 Oct; 258():115567. PubMed ID: 37390512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cereblon in hematologic malignancies.
    Fuchs O
    Blood Rev; 2023 Jan; 57():100994. PubMed ID: 35933246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular glues targeting GSPT1 in cancers: A potent therapy.
    Zhang D; Lin P; Lin J
    Bioorg Chem; 2024 Feb; 143():107000. PubMed ID: 38029571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Degron Blocking Strategy Towards Improved CRL4
    Bouguenina H; Scarpino A; O'Hanlon JA; Warne J; Wang HZ; Wah Hak LC; Sadok A; McAndrew PC; Stubbs M; Pierrat OA; Hahner T; Cabry MP; Le Bihan YV; Mitsopoulos C; Sialana FJ; Roumeliotis TI; Burke R; van Montfort RLM; Choudhari J; Chopra R; Caldwell JJ; Collins I
    Chembiochem; 2023 Dec; 24(23):e202300351. PubMed ID: 37418539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing targeted protein degrader discovery by measuring cereblon engagement in cells.
    Zerfas BL; Huerta F; Liu H; Du G; Gray NS; Jones LH; Nowak RP
    Methods Enzymol; 2023; 681():169-188. PubMed ID: 36764756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation.
    Nie X; Zhao Y; Tang H; Zhang Z; Liao J; Almodovar-Rivera CM; Sundaresan R; Xie H; Guo L; Wang B; Guan H; Xing Y; Tang W
    Chembiochem; 2024 Feb; 25(4):e202300685. PubMed ID: 38116854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders.
    Kroupova A; Spiteri VA; Rutter ZJ; Furihata H; Darren D; Ramachandran S; Chakraborti S; Haubrich K; Pethe J; Gonzales D; Wijaya AJ; Rodriguez-Rios M; Sturbaut M; Lynch DM; Farnaby W; Nakasone MA; Zollman D; Ciulli A
    Nat Commun; 2024 Oct; 15(1):8885. PubMed ID: 39406745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crbn-based molecular Glues: Breakthroughs and perspectives.
    An J; Zhang X
    Bioorg Med Chem; 2024 Apr; 104():117683. PubMed ID: 38552596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation.
    Xie H; Li C; Tang H; Tandon I; Liao J; Roberts BL; Zhao Y; Tang W
    J Med Chem; 2023 Feb; 66(4):2904-2917. PubMed ID: 36749666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Highly Potent CRBN Ligands and Insight into Their Binding Mode through Molecular Docking and Molecular Dynamics Simulations.
    Yan J; Zheng Z
    ChemMedChem; 2023 Mar; 18(5):e202200573. PubMed ID: 36750890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library.
    Powell CE; Du G; Che J; He Z; Donovan KA; Yue H; Wang ES; Nowak RP; Zhang T; Fischer ES; Gray NS
    ACS Chem Biol; 2020 Oct; 15(10):2722-2730. PubMed ID: 32865967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues.
    Yamanaka S; Horiuchi Y; Matsuoka S; Kido K; Nishino K; Maeno M; Shibata N; Kosako H; Sawasaki T
    Nat Commun; 2022 Jan; 13(1):183. PubMed ID: 35013300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation.
    Liu H; Ding X; Liu L; Mi Q; Zhao Q; Shao Y; Ren C; Chen J; Kong Y; Qiu X; Elvassore N; Yang X; Yin Q; Jiang B
    Eur J Med Chem; 2021 Nov; 223():113645. PubMed ID: 34217059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
    Ito T; Yamaguchi Y; Handa H
    Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores.
    Szewczyk SM; Verma I; Edwards JT; Weiss DR; Chekler ELP
    J Med Chem; 2024 Jan; 67(2):1327-1335. PubMed ID: 38170610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
    Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
    J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands for cereblon: 2017-2021 patent overview.
    Kazantsev A; Krasavin M
    Expert Opin Ther Pat; 2022 Feb; 32(2):171-190. PubMed ID: 34704527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery.
    Wang Z; Shaabani S; Gao X; Ng YLD; Sapozhnikova V; Mertins P; Krönke J; Dömling A
    Nat Commun; 2023 Dec; 14(1):8437. PubMed ID: 38114468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.